(CIDRAP News) – Test results on a cluster of Alabama patients hospitalized with similar respiratory symptoms indicated no unusual pathogens but instead a variety of common respiratory viruses and bacteria, state health officials announced today.
(CIDRAP News) – Alabama health officials are investigating a cluster of severe respiratory infections from an unknown origin centered around the Dothan area and have asked the state's health providers to be alert for and report similar cases.
Brown KA, Daneman N, Arora P, et al. The co-seasonality of pneumonia and influenza with Clostridium difficile infection in the United States, 1993-2008. Am J Epidemiol 2013 Jul 1;178(1):118-25
CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2013 Jun 28;62(25):521-4
Dagan R, Patterson S, Juergens C, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccine in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis 2013 (published online Jun 26)
Dimopoulos G, Poulakou G, Pneumatikos IA, et al. Short- versus long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013 (published online Jun 20)
Griffin MR, Zhu U, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013 Jul 11;369(2):155-63
Lujan M, Burgos J, Gallego M, et al. Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults. implications for vaccine strategies. Clin Infect Dis 2013 (published online Sep 24)
Maruyama T, Fujisawa T, Okuno M, et al. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter-cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis 2013 (published online Sep 2)
Melsen WG, Rovers MM, Groenwold RHH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomized prevention studies. Lancet Infect Dis 2013 Aug;13(8):665-71
Papazian L, Roch A, Charles PE, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA 2013 (published online Oct 9)
Richter SS, Heilmann KP, Dohrn CL, et al. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg Infect Dis 2013 Jul;19(7):1074-83
Rudnick W, Liu Z, Shigayeva A, et al. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine 2013 (published online Oct 4)
Self WH, Griffin MR, Zhu Y, et al. The high burden of pneumonia on the US emergency departments during the 2009 influenza pandemic. J Infect 2013 (published online Oct 15)
Sherwin RL, Gray S, Alexander R, et al. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged over 50 years with community-acquired pneumonia. J Infect Dis 2013 (published online Oct 2)
Shorr AF, Zilberberg MD, Kan J, et al. Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study. BMJ Open 2013 Jun 20;3(6)
Shrestha S, Foxman B, Weinberger DM, et al. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med 2013 Jun 26;5(191):191ra84
